Case Studies
Each year, Grant Engine partners with over 200 companies, helping them secure non-dilutive funding from agencies like NIH, BARDA, ARPA-H, DoD, and numerous foundations. With win rates 2x to 4x the industry average, we’ve helped our clients secure hundreds of millions in funding. Here are just a few examples.
Captura BioPharma, a leader in developing medical countermeasures against radiological threats, had an ambitious goal to pursue $82 million in funding from the Biomedical Advanced Research and Development Authority (BARDA) to advance their groundbreaking project, all while maintaining equity: a monumental task that required both precision and strategic foresight. READ THIS CASE STUDY.
Gilgamesh Pharmaceutical, a leader in the development of novel therapies for psychiatric and neurological conditions, urgently needed a UG3/UH3 grant to propel their innovative research into new treatments for drug abuse and dependency. The grant process was daunting due to its competitive nature and the massive amount of funding at stake, occurring only once a year. READ THIS CASE STUDY.
Safe Health Systems (SHS) is a leader in digital healthcare innovation, needed to respond to a highly competitive funding opportunity with a short four-week deadline and little room for error. READ THIS CASE STUDY.
OncoNano Medicine, a pioneering company in the field of nanotechnology for cancer treatment, was at a critical juncture. They needed to secure funding to advance their innovative diagnostic and therapeutic solutions aimed at revolutionizing cancer care while complying with stringent NIH standards. READ THIS CASE STUDY.